,NTBRY4TION4,.IOLRI\,.OF

Antimicrobial Agents

ELSEVIER International Journal of Antimicrobial Agents 6 (1996) 239-242

Author Index

Adeyemi, 0. see G.O. Akpede (6) 91 Akalm, H.E. see D. Gtir (6) 23 Akpede, G.O., 0. Adeyemi and J.P. Ambe, Trends

in the susceptibility to antimicrobial drugs of common pathogens in childhood septicaemia in Nigeria: experience at the University of Mai- duguri Teaching Hospit al, Nigeria, 199 l-l 994 (6) 91

Alstchuler, M. see M.A. Rossi (6) 103 Ambe, J.P. see G.O. Akpede (6) 91 Amichai, B. see E. Finkelstein (6) 189 Anstey, N.M., L.M. Stewart, M. Packard, W.F.

Graney and J.A. Bartlett, Open-label titration study of the safety of R.MP-7 in patients with the acquired immune deficiency syndrome (6) 183

Arguedas, A., C. Loaiza, M. Herrera and E. Mohs, Comparative trial of 3-day azithromycin versus lo-day amoxycillin/clavulanate potassium in the treatment of children with acute otitis media with effusion (6) 233

Arr, M. see E. Ludwig (6) 99 Aumercier, M. see R. Fernandez-Gomez (6) 111

Bartlett, J.A. see N.M. Anstey (6) 183 Bauer, J. see J. Menzel (6) S79 Bauernfeind, A., H. Grimm, W. Klietmann, W. Op-

ferkuch and H. Werner, The influence of sulbac- tam on the in vitro activity of mezlocillin, pipera- cillin and cefotaxime (6) S15

Belliveau, P.P. see K.B. Pate1 (6) 119 Berger-Bachi, B., Factors affecting methicillin re-

sistance in Staphylococcus aureus (6) 13 Bethegnies, G. see R. Fernandez-Gomez (6) 111 Binder, S. see W. Cullmann (6) Sl Bodey, G.P. see R.O. Darouiche (6) 31 Boogaerts, M.A., Antifungal prophylaxis in neu-

tropenic patients (6) 1419 Boon, T. see R. de Gier (6) 27 Borleffs, J.C.C. see M.M.E. Schneider (6) 195 Bouter, K. see R. de Gier (6) 27 Brenciaglia, M.I., A.M. Fornara, M.M. Scaltrito

and F. Dubini, ‘In vitro’ development of met-

0924-8579/96/$32.00 0 1996 Elsevier Science B.V. All rights reserved

ronidazole, erythromycin, amoxicillin and gen- tamicin resistance in Helicobacter pylori (6) 223

Brunetti, E., R. Capellini, C. Meloni, R. Bruno, S.F.A. Patruno, T. Zanardini and C. Filice, Value of culture of pus via percutaneous drainage under sonographic guidance in diagnosis and therapy of pyogenic liver abscess (6) 43

Brunetti, E., R. Capellini, C. Meloni, R. Bruno, T. Zanardini and C. Filice, The value of culture of pus via percutaneous drainage under sonographic guidance in diagnosis and therapy of pyogenic liver abscess (6) 81

Bruno, R. see E. Brunetti (6) 43 Bruno, R. see E. Brunetti (6) 81

Capellini, R. see E. Brunetti (6) 81 Capellini, R. see E. Brunetti (6) 43 Chowdhury, M.N.H., M.R.A. Khaliq and A.M.

Kambal, Penicillin-resistant Streptococcus pneu- moniae in Riyadh, Saudi Arabia (6) 37

Cooper, I., D.J. Isbell, J.A. Kruszynski and L.R. Peterson, Comparative in vitro activity of L-ofloxacin and FK037 to other agents against 10,040 fresh clinical isolates (6) 201

Couto, E. see M.A. Rossi (6) 103 Cuhorst, R. see C.-D. Schwigon (6) S67 Cullmann, W., S. Binder and M. Stieglitz, Sulbac-

tam and clavulanic acid: enzyme kinetics and syn- ergy with ampicillin and mezlocillin (6) Sl

Darouiche, R.O., 1.1. Raad, G.P. Bodey and D.M. Musher, Antibiotic susceptibility of staphylococ- cal isolates from patients with vascular catheter- related bacteremia: potential role of the combina- tion of minocycline and rifampin (6) 31

De Beule, K., Itraconazole: pharmacology, clinical experience and future development (6) 175

De Gier, R., A. Karperien, K. Bouter, M. Zwinkels, J. Verhoef, W. Knol, T. Boon and I.M. Hoepelman, A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treat- ment of complicated urinary tract infections (6) 27

240 Author Inde~~i~ternat~o~al Journal of Antimicrobial Agents 6 (1996) 239-242

Denning, D.W., Aspergillosis: diagnosis and treat- ment (6) 161

Di Bella, A. see M.A. Rossi (6) 103 Dionyssiou-Asteriou, A. see E.J. Giamarellos-

Bourboulis (6) 47 Dubini, F. see MI. Brenciaglia (6) 223 Dujovney, F. see M.A. Rossi (6) 103 DuPont, B. see I.M. Hoepelman (6) 155

Eibach, H.W. see R. Stiglmayer (6) S61

Fernandez-Gomez, R., M. Moutiez, M. Aumercier, G. Bethegnies, M. Luyckx, A. Ouaissi, A. Tartar and C. Sergheraert, 2-Amino diphenylsulfides as new inhibitors of trypanothione reductase (6) 111

Filice, C. see E. Brunetti (6) 81 Filice, C. see E. Brunetti (6) 43 Finkelstein, E., B. Amichai and M.H. Grunwald,

Griseofulvin and its uses (6) 189 Fornara, A.M. see M.I. Brenciaglia (6) 223 Fujiwara, S. see M. Sato (6) 227

Gabor, M. see C.-D. Schwigon (6) S67 Gabor, M. see C.-D. Schwigon (6) S73 Galanternik, L. see M.A. Rossi (6) 103 Georgiev, VS., Treatment and experimental thera-

peutics of blastomycosis (6) 1 Giamarellos-Bourboulis, E.J., P. Grecka, A.

Dionyssiou-Asteriou and H. Giamarellou, In vitro influence of polyunsaturated fatty acids on nosocomial Pseudomonas aeruginosa: a prelimi- nary report (6) 47

Giamarellou, H. see E.J. Giamarellos-Bourboulis

(6) 47 Gomez, N. see M.A. Rossi (6) 103 Graney, W.F. see N.M. Anstey (6) 183 Grecka, P. see E.J. Giamarellos-Bourboulis (6) 47 Grimm, H., Comparative in vitro studies on the

P-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Entero- bacteriaceae (6) S9

Grimm, H. see A. Bauernfeind (6) S15 Grubb, W.B. see E.E. Udo (6) 51 Grunwald, M.H. see E. Finkelstein (6) 189 Giir, D., S. Unal and H.E. Akahn, Resistance pat-

terns in Turkey (6) 23 Gutsche, F. see M. Wenzel (6) S35

Hardie, N. see M.A. Rossi (6) 103 Hartmann, J. see C.-D. Schwigon (6) S73 Heilmann, F. see H. Werner (6) S27

Heizmann, W. see H. Werner (6) S27 Heizmann, W.R. see K. Manncke (6) S47 Herrera, M. see A. Arguedas (6) 233 Hoepelman, I.M. see R. de Gier (6) 27 Hoepelman, I.M., Introduction (6) 129 Hoepelman, 1-M. and B. DuPont, Oral candidiasis:

the clinical challenge of resistance and manage- ment (6) 155

Hoepelman, I.M. see M.M.E. Schneider (6) 195

Iinuma, M. see M. Sato (6) 227 Isbell, D.J. see I. Cooper (6) 201

Kakizoe, T. see Y. Tokue (6) 123 Kambal, A.M. see M.N.H. Chowdhury (6) 37 Karperien, A. see R. de Gier (6) 27 Khaliq, M.R.A. see M.N.H. Chowdhury (6) 37 Klempa, I. see J. Menzel (6) S79 Klietmann, W. see A. Bauernfeind (6) S15 Knol, W. see R. de Gier (6) 27 Konkoly Thege, M. see E. Ludwig (6) 99 Kiirner, J. see R. Stiglmayer (6) S61 Kovacs, G. see E. Ludwig (6) 99 Kruszynski, J.A. see I. Cooper (6) 201 Kubo, S. see T. Matsumoto (6) 85 Kumazawa, J. see T. Matsumoto (6) 85 Kureshiro, H. see M. Sato (6) 227

Loaiza, C. see A. Arguedas (6) 233 Lode, H., Preface (6) Sv Ludwig, E., M. Konkoly Thege, M. Arr and G.

Kovacs, Resistance of some selected pathogens to antimicrobials in Hungary (6) 99

Luyckx, M. see R. Fernandez-Gomez (6) 111

Manncke, K., M. Springsklee, W.R. Heizmann and H.G. Sonntag, Sulbactam in combination with mezlocillin, piperacillin or cefotaxime: clinical and bacteriological findings in the treatment of serious bacterial infections (6) S47

Marker, X. see H. Scholz (6) S41 Matsumoto, T., T. Nagafuji, K. Takahashi, S.

Kubo, M. Sakumoto, Y. Mizunoe and J. Ku- mazawa, Ofloxacin and fleroxacin enhance super- oxide production in human polymorphonuclear leukocytes by increasing phosphorylation in the signal transduction pathway (6) 85

Meloni, C. see E. Brunetti (6) 81 Meloni, C. see E. Brunetti (6) 43 Menzel, J., J. Bauer, E. von Pritzbuer and I.

Klempa, Perioperative use of ampicillin/sulbac-

Author Index/International Journal of Antimicrobial Agents 6 (1996) 239-242 241

tam, cefoxitin and piperacillin/metronidazole in ternik, M. Woloj, N. Hardie, J. Stellin, M. Schli- elective colon and rectum surgery: a prospective pak and T. O’Brien, Survey of the levels of anti- and randomized quality control study in 422 pa- microbial resistance in Argentina: WHONET tients (6) S79 program - 1991 to 1994 (6) 103

Meunier, F., Current clinical issues on mycoses in neutropenic patients (6) 135

Miyazaki, T. see M. Sato (6) 227 Mizunoe, Y. see T. Matsumoto (6) 85 Mohs, E. see A. Argued,as (6) 233 M&singer, R. see C.D. Schwigon (6) S73 Moutiez, M. see R. Fernandez-Gomez (6) 111 Musher, D.M. see R.O. Darouiche (6) 31

Nagafuji, T. see T. Matsumoto (6) 85 Nicolau, D.P. see K.B. F’atel (6) 119 Nightingale, C.H. see K.B. Pate1 (6) 119 Noda, T. see Y. Tokue (6) 123

O’Brien, T. see M.A. Rossi (6) 103 Oberling, M. see C.D. Schwigon (6) S73 Odds, F.C., Epidemiological shifts in opportunistic

and nosocomial Candida infections: mycological aspects (6) 141

Odds, F.C., Resistance o’f clinically important yeasts to antifungal agents (6) 145

Ohkura, H. see Y. Tokue (6) 123 Opferkuch, W. see A. Bauernfeind (6) S15 Ouaissi, A. see R. Fernandez-Gomez (6) 111

Packard, M. see N.M. Anstey (6) 183 Patel, K.B., P.P. Belliveau, C.H. Nightingale, D.P.

Nicolau and R. Quintiliani, Absorption of cip- rofloxacin in febrile and afebrile patients (6) 119

Patruno, S.F.A. see E. Brunetti (6) 43 Perez-Trallero, E. and C. Zigorraga, Resistance to

antimicrobial agents as a public health problem: importance of the use of antibiotics in animals (6) 59

Peterson, L.R. see I. Cooper (6) 201 Principi, N., Management issues in paediatric

pharyngitis and otitis media (6) 65

Quintiliani, R. see K.B. Pate1 (6) 119

Raad, 1.1. see R.O. Darouiche (6) 31 Rader, K. see A. Wildfeuer (6) S31 Rinaldi, M.G., Epidemiology of mycoses in the

HIV-infected patient: clinical aspects (6) 131 Rockstroh, T. see H. Scholz (6) S41 Rossi, M.A., M. Tokumoto, E. Couto, A. Di Bella,

M. Alstchuler, N. Gomez, F. Dujovney, L. Galan-

Saito, D. see Y. Tokue (6) 123 Sakumoto, M. see T. Matsumoto (6) 85 Sato, M., H. Tsuchiya, T. Miyazaki, S. Fujiwara,

R. Yamaguchi, H. Kureshiro and M. Iinuma, An- tibacterial activity of hydroxychalcone against methicillin-resistant Staphylococcus aurem (6) 227

Scaltrito, M.M. see M.I. Brenciaglia (6) 223 Schlipak, M. see M.A. Rossi (6) 103 Schneider, M.M.E., M.J.W. Sprenger, I.M.

Hoepelman, Y. van der Graaf and J.C.C. Bor- leffs, Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1 (6) 195

Scholz, H., X. Marker and T. Rockstroh, Treat- ment of bacterial infections in children with sult- amicillin (6) S41

Schubert, U. see C.D. Schwigon (6) S73 Schlitz, W., Efficacy and safety of sultamicillin (750

mg bid) compared with amoxycillin/clavulanate (625 mg tid) in patients with uncomplicated uri- nary tract infections (6) S55

Schwarck, H. see C.D. Schwigon (6) S73 Schwigon, C.-D., R. Cuhorst, M. Gabor, J.

Zinndorf and M. Springsklee, Comparison of sul- bactam/ampicillin and cefuroxime in infections of the lower respiratory tract: results of a prospec- tive, randomized and comparative study (6) S67

Schwigon, C.-D., M. Gabor, J. Hartmann, R. Mbs- singer, M. Oberling, U. Schubert, H. Schwarck, M. Springsklee and J. Zinndorf, Which antibiotic is better for the treatment of infections of the lower respiratory tract? (6) S73

Sekiya, T. see Y. Tokue (6) 123 Senft, H.H. see R. Stiglmayer (6) S61 Sergheraert, C. see R. Fernandez-Gomez (6) 111 Shimosato, Y. see Y. Tokue (6) 123 Sonntag, H.G. see K. Manncke (6) S47 Sprenger, M.J.W. see M.M.E. Schneider (6) 195 Springsklee, M. see K. Manncke (6) S47 Springsklee, M. see C.-D. Schwigon (6) S67 Springsklee, M. see C.-D. Schwigon (6) S73 Stellin, J. see M.A. Rossi (6) 103 Stewart, L.M. see N.M. Anstey (6) 183 Stieglitz, M. see W. Cullmann (6) Sl Stiglmayer, R., H.H. Senft, H.W. Eibach and J.

Korner, Sulbactam/ampicillin versus cefoxitin in

242 Author Indexllnternational Journal of Antimicrobial Agents 6 (1996) 239-242

the treatment of gynaecological infections: an an- tibiotic therapeutic study (6) S61

Sugano, K. see Y. Tokue (6) 123

Takahashi, K. see T. Matsumoto (6) 85 Tartar, A. see R. Fernandez-Gomez (6) 111 Tokue, Y., K. Sugano, T. Noda, D. Saito, Y. Shi-

mosato, H. Ohkura, T. Kakizoe and T. Sekiya, DNA gyrase gyrA gene mutations in ofloxacin- resistant Staphylococcus aureus (6) 123

Tokumoto, M. see M.A. Rossi (6) 103 Tsuchiya, H. see M. Sato (6) 227

Udo, E.E. and W.B. Grubb, Detection of an inte- grated tetracycline-resistance plasmid in Staphy- iococcus azmxs from a Nigerian hospital (6) 51

Unal, S. see D. Giir (6) 23

Van der Graaf, Y, see M.M.E. Schneider (6) 195 Verhoef, J. see R. de Gier (6) 27 Viviani, M.-A., Cryptococcal meningitis: Diagnosis

and treatment (6) 169 Von Pritzbuer, E. see J. Menzel (6) S79

Wenzel, M., A. Wildfeuer and F. Gutsche, Pharma-

cokinetics of ampicillin/sulbactam in patients un- dergoing colorectal surgery: measurements in serum, the colonic wall and in tissue at the incision site (6) S35

Werner, H. see A. Bauernfeind (6) S15 Werner, H., W. Heizmann and F. Heilmann, The

effect of a combination of ampicillin and sulbac- tam against clinical isolates of anaerobic bacteria (6) S27

Wildfeuer, A. see M. Wenzel (6) S35 Wildfeuer, A. and K. Raider, Stability of /?-lacta-

mase inhibitors and/?-lactam antibiotics in paren- teral dosage forms and in body fluids and tissue homogenates: a comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin (6) S3 1

Woloj, M. see M.A. Rossi (6) 103

Yamaguchi, R. see M. Sato (6) 227

Zanardini, T. see E. Brunetti (6) 43 Zanardini, T. see E. Brunetti (6) 81 Zigorraga, C. see E. Perez-Trallero (6) 59 Zinndorf, J. see C.-D. Schwigon (6) S67 Zinndorf, J. see C.-D. Schwigon (6) S73 Zwinkels, M. see R. de Gier (6) 27